Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104059036B enables high-yield synthesis of Ranitidine intermediate. Discover cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101691319B details a mild Pd-catalyzed route to fluorinated piperidines, offering high selectivity and reduced toxicity for API intermediates.
Patent CN106048648A reveals electrochemical catalytic synthesis reducing heavy metal waste. Offers cost reduction in fine chemical manufacturing and reliable supply chain solutions.
Novel process for sialic acid derivatives with active carbonyls for drug half-life extension. Reliable supplier for high-purity intermediates.
Patent CN106279239B reveals a metal-free Wittig-Horner route for polyenic compounds. Achieve superior purity and scalable manufacturing for vitamin D analogues.
Patent CN110511141A reveals a high-yield synthetic route for Apronal. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Advanced synthesis of (S)-Oxiracetam via patent CN102603599B. High purity >99%, cost-effective route using ion exchange. Ideal for reliable API supplier partnerships.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Novel patent CN117756809A offers high-yield synthesis for Vibegron intermediate. Enhances supply chain stability and reduces manufacturing complexity for global pharmaceutical partners.
Novel Wittig condensation and iron reduction process for high-purity combretastatin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN109293593A enables metal-free synthesis of iodoisoxazoles. Enhances supply chain reliability and reduces costs for pharmaceutical intermediate manufacturing globally.
Patent CN114853721A reveals a mild, metal-free synthesis for sulfonylcoumarins, offering cost-effective supply chain solutions for pharmaceutical intermediates.
Patent CN114423764B reveals a biomimetic total synthesis route for morphine derivatives, offering high-purity intermediates and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel dual-catalyst method reduces genotoxic impurities in nifedipine intermediates, offering cost-effective scale-up for API manufacturers.
Patent CN113233979B reveals a noble-metal-free route for Vitamin A intermediates, offering significant cost reduction and improved selectivity for global supply chains.
Patent CN112430228B details a novel Rh-catalyzed route for chiral 2,3-dihydrobenzo[b]thiophene 1,1-dioxide, offering superior stereoselectivity and scalable manufacturing for API intermediates.
Advanced patent CN101010289B details a streamlined synthesis for 4,5-diaminoshikimic acid derivatives. Discover cost-effective manufacturing and supply chain advantages for antiviral intermediates.
Patent CN106146271B reveals a palladium-catalyzed route for diaryl ketones offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108929253B details a high-yield route for pleuromutilin compounds, offering cost-effective antibiotic intermediate manufacturing solutions.
Patent CN117327010A reveals a novel Pd-catalyzed C-H amination route for high-purity 3-tert-butylaminoacrylamide derivatives, offering significant supply chain and cost advantages.